Evidence map›Paper›PMID 32467090›Full record

GuidelineGut2020

Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology.

James Neuberger, Jai Patel, Helen Caldwell, Susan Davies, Vanessa Hebditch, Coral Hollywood, Stefan Hubscher, Salil Karkhanis, Will Lester, Nicholas Roslund and 3 more

2 registry-linked trialsAbstract readPractice Guideline
In one paragraph

Guideline in Gut, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 221 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
221citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07506642 completednot on this mapstarted 2023, after this paper: background citation

Patient-Reported Experience Measures Of EUS-Guided Versus Percutaneous Liver Biopsy: A Prospective Randomized Controlled Study

TypeobservationalSponsorUniversity Hospital MuensterRan2023 to 2024Enrolled102ConditionsChronic Liver Disease (CLD), Liver Transplantation, CirrhosisArmsEUS Liver Biopsy, Percutaneous Liver Biopsy
NCT07701031 completednot on this mapstarted 2023, after this paper: background citation

Assessing EUS and Percutaneous Untargeted Liver Biopsy Quality: A Sequential-Period Cluster-Randomized Study

TypeobservationalSponsorUniversity Hospital MuensterRan2023 to 2024Enrolled146ConditionsLiver Cirrhosis, Liver Disease Chronic, Liver TransplantArmsEUS Liver biopsy 19G FNA, EUS LB 19G FNB, EUS LB 22G FNB, EUS LB 22G FNA, PC-LB 18G Trucut
3 · Its place in the literature

Who cites it

221 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Pooled it
  4. ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. [Noninvasive scores for predicting liver-related events in patients with metabolic dysfunction-associated fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Article
  16. Article
  17. Article
  18. Endo-Hepatology: Paradigm Shift in Endosonographic Diagnosis for Liver Disease to Digestive Endoscopy.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
    Review
  19. Article
  20. Article

161 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

James NeubergerLiver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK jamesneuberger@hotmail.co.uk.ORCID 0000-0002-6079-002X
Jai PatelDepartment of Vascular Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Helen CaldwellLiver Unit, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
Susan DaviesDepartment of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Vanessa HebditchBritish Liver Trust, Ringwood, UK.
Coral HollywoodDepartment of Gastroenterology, Gloucestershire Royal Hospital, Gloucester, UK.
Stefan HubscherDepartment of Pathology, University of Birmingham, Birmingham, UK.
Salil KarkhanisDepartment of Radiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Will LesterDepartment of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
Nicholas RoslundPatient Representative, London, UK.
Rebecca WestBritish Liver Trust, Ringwood, UK.
Judith I WyattDepartment of Pathology, St James University Hospital, Leeds, UK.
Mathis HeydtmannDepartment of Gastroenterology, Royal Alexandra Hospital, Glasgow, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes. There are several approaches to liver biopsy but predominantly percutaneous or transvenous approaches are used. A wide choice of needles is available and the approach and type of needle used will depend on the clinical state of the patient and local expertise but, for non-lesional biopsies, a 16-gauge needle is recommended. Many patients with liver disease will have abnormal laboratory coagulation tests or receive anticoagulation or antiplatelet medication. A greater understanding of the changes in haemostasis in liver disease allows for a more rational, evidence-based approach to peri-biopsy management. Overall, liver biopsy is safe but there is a small morbidity and a very small mortality so patients must be fully counselled. The specimen must be of sufficient size for histopathological interpretation. Communication with the histopathologist, with access to relevant clinical information and the results of other investigations, is essential for the generation of a clinically useful report.

Indexed as

Antibiotic ProphylaxisAnticoagulantsBiopsyBlood Coagulation TestsContraindications, ProcedureEndoscopic Ultrasound-Guided Fine Needle AspirationHumansInformed ConsentInterdisciplinary CommunicationLaparoscopyLiverNeedlesPatient SelectionPostoperative CareProfessional RoleAnticoagulantshistopathologyinterventional radiologyliver biopsy

Identifiers

PMID32467090
PMCPMC7398479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.